"From early phase exploratory drug discovery and safety research through clinical development to regulatory submission and beyond, SNBL provides customized services quickly and efficiently to reduce the time products enter and move through human clinical tests, meet regulatory requirements, and rapidly reach their markets."

—Ryoichi Nagata, M.D., Ph.D
Chairman and CEO

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is one of the largest CROs in Japan, with over a thousand employees, established in 1957 and based in Tokyo.  SNBL supports the pharmaceutical industry with a full range of drug development services, including: safety research, clinical pharmacology, and preclinical, Phase I, Phase II, and Phase III clinical trials. In addition to SNBL Clinical Pharmacology Center, Inc. in Baltimore, the company has facilities and offices in Everett, Washington, Europe and China.

Our Vision

Our Mission

SNBL CPC believes that

• The human condition can be improved by the appropriate use of science and technology.
• Quality health care promotes a satisfying quality of life.
• Quality research demands an on-going dedication to education and training.
• Partnerships, collaborations, and civic participation are fundamental to improving organizations and institutions.
• The inclusion of diversity is essential for creativity and innovation.
• Truthful and accurate performance of our functions and in our relationships is essential for long-term success.

At SNBL CPC, we

• Actively participate in the preservation of the environment.
• Respect life above all else.
• Support the recovery of human health.
• Encourage improvements in human welfare.
• Contribute to advances in medicine.
• Strive to prevent human diseases.
• Seek the human right to be secure.
• Adhere to safety standards within the research field.
• Work as a team.
• Value reliability.
• Grow with our jobs.
• Contribute to the happiness of humankind.